Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 156 de 371.

Grafa
Technology

AEVEX Aerospace delivers $12.3M wildfire detection platform to Oregon

AEVEX (NYSE:AVEX) announced the delivery of a $12.3 million multi-mission DHC-6-300 Twin Otter aircraft to the Oregon Department of Forestry (ODF), providing specialized airborne data gathering capabilities just as the region enters its peak summer wildfire cycle.

Leia mais: AEVEX Aerospace delivers $12.3M wildfire detection platform to Oregon
Grafa

WisdomTree hits all-time high AUM following record May inflows and Atlantic House acquisition

WisdomTree (NYSE:WT) announced that its firm-wide assets under management reached an all-time high in May 2026, fueled by record asset volumes across its U.S., European, and Digital Asset segments, alongside the formal closing of a key international acquisition.

Leia mais: WisdomTree hits all-time high AUM following record May inflows and Atlantic House acquisition
Grafa

Vertex’s CRISPR therapy CASGEVY eliminates symptoms in young kids, eyes FDA expansion

Vertex Pharmaceuticals (NASDAQ:VRTX) announced highly anticipated clinical data demonstrating that its CRISPR-based gene-editing therapy, CASGEVY, matches its highly successful adult profile when used in younger children.

Leia mais: Vertex’s CRISPR therapy CASGEVY eliminates symptoms in young kids, eyes FDA expansion
Grafa

Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial

Medicus Pharma (NASDAQ:MDCX) submitted an Investigational New Drug (IND) application to the Department of Health, Abu Dhabi, seeking authorization to launch a genomics-enabled Phase 2a clinical trial evaluating its candidate Teverelix in women with symptomatic endometriosis.

Leia mais: Medicus Pharma files Abu Dhabi regulatory application for endometriosis trial
Grafa

Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial

Rafael Holdings (NYSE:RFL) reported its third-quarter fiscal 2026 financial results alongside a critical clinical milestone, finalizing the active clinical phase of its lead rare disease program and clearing the path for a regulatory submission later this year.

Leia mais: Rafael Holdings climbs on completion of pivotal Phase 3 rare disease trial
Grafa

Johnson & Johnson hit with $32M mesothelioma verdict in Los Angeles talc trial

A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal cancer was directly caused by decades of exposure to asbestos-contaminated talc in the company's iconic baby powder.

Leia mais: Johnson & Johnson hit with $32M mesothelioma verdict in Los Angeles talc trial
Grafa
Technology

Judge denies Meta and Google motions for new trial in landmark social media harm case

A California state court judge has denied post-trial motions by Meta Platforms (NASDAQ:META) and Google’s (NASDAQ:GOOGL) YouTube seeking a new trial, upholding a landmark jury verdict that found the tech giants liable for intentionally designing addictive features that harm the mental health of youth.

Leia mais: Judge denies Meta and Google motions for new trial in landmark social media harm case
Grafa

Nexalin Technology reports positive results from neurostimulation anxiety trial

Nexalin Technology (NASDAQ:NXL) reported the successful completion of an 8-week, single-center, prospective, open-label clinical trial evaluating its proprietary 15 milliamp (mA), 77.5 Hz Deep Intracranial Frequency Stimulation (DIFS™) protocol in adults with generalized anxiety disorder and comorbid insomnia.

Leia mais: Nexalin Technology reports positive results from neurostimulation anxiety trial
Grafa
Media

Paramount-Warner megadeal faces EU scrutiny over Gulf sovereign funding

Paramount Skydance's (NASDAQ:PSKY) proposed $110 billion acquisition of Warner Bros. Discovery (NASDAQ:WBD) has come under formal scrutiny from the European Union over its financial backing from Middle Eastern sovereign wealth funds, according to a European Commission filing.

Leia mais: Paramount-Warner megadeal faces EU scrutiny over Gulf sovereign funding